World Diabetes Day 14 November (3) The Lancet: Insulin, the patient, and the health professional

12 November, 2021

Extracts below from a Comment in this week's Lancet, emphasising the importance of patent education and empowerment.

CITATION: COMMENT| VOLUME 398, ISSUE 10313, P1785-1786, NOVEMBER 13, 2021

Insulin, the patient, and the health professional

Simon R Heller et al.

Published:November 13, 2021DOI:https://doi.org/10.1016/S0140-6736(21)02450-8

'People who live with type 1 diabetes are asked to learn and implement complex skills, calculating insulin dose according to current blood glucose and anticipated carbohydrate intake at each meal, every day of their lives...

'In many low-income and middle-income countries (LMICs), few patients can afford modern insulin analogues let alone devices to record glucose continuously or adjust insulin automatically. But there are other gaps in implementing diabetes management programmes in LMICs, including insufficient knowledge, inadequate motivation, time constraints, social stigma, excessive patient burden for health-care professionals, and scarcity of a systematic multidisciplinary team approach. The provision of free medicines and glucose monitoring would make a major difference. Two multinational surveys involving participants with type 1 diabetes from the Middle East and Latin America showed that those who received diabetes education were more likely to practise self-management and attain glycaemic targets than those who did not. These data highlight how strategies that encourage self-management through diabetes education can help to reach glycaemic targets at low cost in all countries.'

Neil Pakenham-Walsh, HIFA Coordinator, neil@hifa.org www.hifa.org